The global market for Dry Powder Inhaler Device was estimated to be worth US$ 786.6 million in 2023 and is forecast to a readjusted size of US$ 1103.8 million by 2030 with a CAGR of 4.9% during the forecast period 2024-2030

Dry Powder Inhaler Device - Market

A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.

GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, etc. are the key players in the global Dry Powder Inhaler Device market. Top 4 took up more than 30% of the global market.

From the view of region, USA have a larger consumption market share which account for about 35% of total share. Europe hold a market share of about 25%. In addition, Asia Pacific is also play important role in Global market.

Dry Powder Inhaler Device main application area is Asthma This sector hold a market share of over 80%. Then followed by the COPD.

According to the Segmentation of types, all the market of Dry Powder Inhaler Device can be divided as follows: Multi-dose, Single-dose.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dry Powder Inhaler Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Dry Powder Inhaler Device by region & country, by Type, and by Application.

The Dry Powder Inhaler Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Powder Inhaler Device.

Market Segmentation

Scope of Dry Powder Inhaler Device - Market Report

Report Metric	Details
Report Name	Dry Powder Inhaler Device - Market
Forecasted market size in 2030	US$ 1103.8 million
CAGR	4.9%
Forecasted years	2024 - 2030
Segment by Type:	Single Dose Multi Dose
Segment by Application	Asthma COPD Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind, Mylan, Novartis, Schering/Merck, Teva, Vectura
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Dry Powder Inhaler Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Dry Powder Inhaler Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Dry Powder Inhaler Device in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Dry Powder Inhaler Device - Market size in 2030?

Ans: The Dry Powder Inhaler Device - Market size in 2030 will be US$ 1103.8 million.

What is the Dry Powder Inhaler Device - Market share by region?

Ans: From the view of region, USA have a larger consumption market share which account for about 35% of total share. Europe hold a market share of about 25%.

What is the Dry Powder Inhaler Device - Market share by application?

Ans: Dry Powder Inhaler Device main application area is Asthma This sector hold a market share of over 80%.

Who are the main players in the Dry Powder Inhaler Device - Market report?

Ans: The main players in the Dry Powder Inhaler Device - Market are GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind, Mylan, Novartis, Schering/Merck, Teva, Vectura

What are the Application segmentation covered in the Dry Powder Inhaler Device - Market report?

Ans: The Applications covered in the Dry Powder Inhaler Device - Market report are Asthma, COPD, Others

What are the Type segmentation covered in the Dry Powder Inhaler Device - Market report?

Ans: The Types covered in the Dry Powder Inhaler Device - Market report are Single Dose, Multi Dose

1 Market Overview

1.1 Dry Powder Inhaler Device Product Introduction

1.2 Global Dry Powder Inhaler Device Market Size Forecast

1.2.1 Global Dry Powder Inhaler Device Sales Value (2019-2030)

1.2.2 Global Dry Powder Inhaler Device Sales Volume (2019-2030)

1.2.3 Global Dry Powder Inhaler Device Sales Price (2019-2030)

1.3 Dry Powder Inhaler Device Market Trends & Drivers

1.3.1 Dry Powder Inhaler Device Industry Trends

1.3.2 Dry Powder Inhaler Device Market Drivers & Opportunity

1.3.3 Dry Powder Inhaler Device Market Challenges

1.3.4 Dry Powder Inhaler Device Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Dry Powder Inhaler Device Players Revenue Ranking (2023)

2.2 Global Dry Powder Inhaler Device Revenue by Company (2019-2024)

2.3 Global Dry Powder Inhaler Device Players Sales Volume Ranking (2023)

2.4 Global Dry Powder Inhaler Device Sales Volume by Company Players (2019-2024)

2.5 Global Dry Powder Inhaler Device Average Price by Company (2019-2024)

2.6 Key Manufacturers Dry Powder Inhaler Device Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Dry Powder Inhaler Device Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Dry Powder Inhaler Device

2.9 Dry Powder Inhaler Device Market Competitive Analysis

2.9.1 Dry Powder Inhaler Device Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Dry Powder Inhaler Device Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Powder Inhaler Device as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Single Dose

3.1.2 Multi Dose

3.2 Global Dry Powder Inhaler Device Sales Value by Type

3.2.1 Global Dry Powder Inhaler Device Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Dry Powder Inhaler Device Sales Value, by Type (2019-2030)

3.2.3 Global Dry Powder Inhaler Device Sales Value, by Type (%) (2019-2030)

3.3 Global Dry Powder Inhaler Device Sales Volume by Type

3.3.1 Global Dry Powder Inhaler Device Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Dry Powder Inhaler Device Sales Volume, by Type (2019-2030)

3.3.3 Global Dry Powder Inhaler Device Sales Volume, by Type (%) (2019-2030)

3.4 Global Dry Powder Inhaler Device Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Asthma

4.1.2 COPD

4.1.3 Others

4.2 Global Dry Powder Inhaler Device Sales Value by Application

4.2.1 Global Dry Powder Inhaler Device Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Dry Powder Inhaler Device Sales Value, by Application (2019-2030)

4.2.3 Global Dry Powder Inhaler Device Sales Value, by Application (%) (2019-2030)

4.3 Global Dry Powder Inhaler Device Sales Volume by Application

4.3.1 Global Dry Powder Inhaler Device Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Dry Powder Inhaler Device Sales Volume, by Application (2019-2030)

4.3.3 Global Dry Powder Inhaler Device Sales Volume, by Application (%) (2019-2030)

4.4 Global Dry Powder Inhaler Device Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Dry Powder Inhaler Device Sales Value by Region

5.1.1 Global Dry Powder Inhaler Device Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Dry Powder Inhaler Device Sales Value by Region (2019-2024)

5.1.3 Global Dry Powder Inhaler Device Sales Value by Region (2025-2030)

5.1.4 Global Dry Powder Inhaler Device Sales Value by Region (%), (2019-2030)

5.2 Global Dry Powder Inhaler Device Sales Volume by Region

5.2.1 Global Dry Powder Inhaler Device Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Dry Powder Inhaler Device Sales Volume by Region (2019-2024)

5.2.3 Global Dry Powder Inhaler Device Sales Volume by Region (2025-2030)

5.2.4 Global Dry Powder Inhaler Device Sales Volume by Region (%), (2019-2030)

5.3 Global Dry Powder Inhaler Device Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Dry Powder Inhaler Device Sales Value, 2019-2030

5.4.2 North America Dry Powder Inhaler Device Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Dry Powder Inhaler Device Sales Value, 2019-2030

5.5.2 Europe Dry Powder Inhaler Device Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Dry Powder Inhaler Device Sales Value, 2019-2030

5.6.2 Asia Pacific Dry Powder Inhaler Device Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Dry Powder Inhaler Device Sales Value, 2019-2030

5.7.2 South America Dry Powder Inhaler Device Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Dry Powder Inhaler Device Sales Value, 2019-2030

5.8.2 Middle East & Africa Dry Powder Inhaler Device Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Dry Powder Inhaler Device Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Dry Powder Inhaler Device Sales Value

6.2.1 Key Countries/Regions Dry Powder Inhaler Device Sales Value, 2019-2030

6.2.2 Key Countries/Regions Dry Powder Inhaler Device Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Dry Powder Inhaler Device Sales Value, 2019-2030

6.3.2 United States Dry Powder Inhaler Device Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Dry Powder Inhaler Device Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Dry Powder Inhaler Device Sales Value, 2019-2030

6.4.2 Europe Dry Powder Inhaler Device Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Dry Powder Inhaler Device Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Dry Powder Inhaler Device Sales Value, 2019-2030

6.5.2 China Dry Powder Inhaler Device Sales Value by Type (%), 2023 VS 2030

6.5.3 China Dry Powder Inhaler Device Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Dry Powder Inhaler Device Sales Value, 2019-2030

6.6.2 Japan Dry Powder Inhaler Device Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Dry Powder Inhaler Device Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Dry Powder Inhaler Device Sales Value, 2019-2030

6.7.2 South Korea Dry Powder Inhaler Device Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Dry Powder Inhaler Device Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Dry Powder Inhaler Device Sales Value, 2019-2030

6.8.2 Southeast Asia Dry Powder Inhaler Device Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Dry Powder Inhaler Device Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Dry Powder Inhaler Device Sales Value, 2019-2030

6.9.2 India Dry Powder Inhaler Device Sales Value by Type (%), 2023 VS 2030

6.9.3 India Dry Powder Inhaler Device Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 GlaxoSmithKline

7.1.1 GlaxoSmithKline Company Information

7.1.2 GlaxoSmithKline Introduction and Business Overview

7.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)

7.1.4 GlaxoSmithKline Dry Powder Inhaler Device Product Offerings

7.1.5 GlaxoSmithKline Recent Development

7.2 AstraZeneca

7.2.1 AstraZeneca Company Information

7.2.2 AstraZeneca Introduction and Business Overview

7.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)

7.2.4 AstraZeneca Dry Powder Inhaler Device Product Offerings

7.2.5 AstraZeneca Recent Development

7.3 Boehringer Ingelheim

7.3.1 Boehringer Ingelheim Company Information

7.3.2 Boehringer Ingelheim Introduction and Business Overview

7.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Boehringer Ingelheim Dry Powder Inhaler Device Product Offerings

7.3.5 Boehringer Ingelheim Recent Development

7.4 Chiesi

7.4.1 Chiesi Company Information

7.4.2 Chiesi Introduction and Business Overview

7.4.3 Chiesi Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Chiesi Dry Powder Inhaler Device Product Offerings

7.4.5 Chiesi Recent Development

7.5 Cipla

7.5.1 Cipla Company Information

7.5.2 Cipla Introduction and Business Overview

7.5.3 Cipla Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Cipla Dry Powder Inhaler Device Product Offerings

7.5.5 Cipla Recent Development

7.6 3M

7.6.1 3M Company Information

7.6.2 3M Introduction and Business Overview

7.6.3 3M Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)

7.6.4 3M Dry Powder Inhaler Device Product Offerings

7.6.5 3M Recent Development

7.7 Hovione

7.7.1 Hovione Company Information

7.7.2 Hovione Introduction and Business Overview

7.7.3 Hovione Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Hovione Dry Powder Inhaler Device Product Offerings

7.7.5 Hovione Recent Development

7.8 Mannkind

7.8.1 Mannkind Company Information

7.8.2 Mannkind Introduction and Business Overview

7.8.3 Mannkind Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Mannkind Dry Powder Inhaler Device Product Offerings

7.8.5 Mannkind Recent Development

7.9 Mylan

7.9.1 Mylan Company Information

7.9.2 Mylan Introduction and Business Overview

7.9.3 Mylan Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Mylan Dry Powder Inhaler Device Product Offerings

7.9.5 Mylan Recent Development

7.10 Novartis

7.10.1 Novartis Company Information

7.10.2 Novartis Introduction and Business Overview

7.10.3 Novartis Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Novartis Dry Powder Inhaler Device Product Offerings

7.10.5 Novartis Recent Development

7.11 Schering/Merck

7.11.1 Schering/Merck Company Information

7.11.2 Schering/Merck Introduction and Business Overview

7.11.3 Schering/Merck Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Schering/Merck Dry Powder Inhaler Device Product Offerings

7.11.5 Schering/Merck Recent Development

7.12 Teva

7.12.1 Teva Company Information

7.12.2 Teva Introduction and Business Overview

7.12.3 Teva Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Teva Dry Powder Inhaler Device Product Offerings

7.12.5 Teva Recent Development

7.13 Vectura

7.13.1 Vectura Company Information

7.13.2 Vectura Introduction and Business Overview

7.13.3 Vectura Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Vectura Dry Powder Inhaler Device Product Offerings

7.13.5 Vectura Recent Development

8 Industry Chain Analysis

8.1 Dry Powder Inhaler Device Industrial Chain

8.2 Dry Powder Inhaler Device Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Dry Powder Inhaler Device Sales Model

8.5.2 Sales Channel

8.5.3 Dry Powder Inhaler Device Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Dry Powder Inhaler Device Market Trends

Table 2. Dry Powder Inhaler Device Market Drivers & Opportunity

Table 3. Dry Powder Inhaler Device Market Challenges

Table 4. Dry Powder Inhaler Device Market Restraints

Table 5. Global Dry Powder Inhaler Device Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Dry Powder Inhaler Device Revenue Market Share by Company (2019-2024)

Table 7. Global Dry Powder Inhaler Device Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Dry Powder Inhaler Device Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Dry Powder Inhaler Device Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Dry Powder Inhaler Device Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Dry Powder Inhaler Device Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Dry Powder Inhaler Device

Table 13. Global Dry Powder Inhaler Device Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Powder Inhaler Device as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Dry Powder Inhaler Device Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Dry Powder Inhaler Device Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Dry Powder Inhaler Device Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Dry Powder Inhaler Device Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Dry Powder Inhaler Device Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Dry Powder Inhaler Device Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Dry Powder Inhaler Device Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Dry Powder Inhaler Device Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Dry Powder Inhaler Device Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Dry Powder Inhaler Device Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Dry Powder Inhaler Device Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Dry Powder Inhaler Device Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Dry Powder Inhaler Device Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Dry Powder Inhaler Device Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Dry Powder Inhaler Device Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Dry Powder Inhaler Device Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Dry Powder Inhaler Device Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Dry Powder Inhaler Device Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Dry Powder Inhaler Device Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Dry Powder Inhaler Device Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Dry Powder Inhaler Device Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Dry Powder Inhaler Device Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Dry Powder Inhaler Device Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Dry Powder Inhaler Device Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Dry Powder Inhaler Device Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Dry Powder Inhaler Device Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Dry Powder Inhaler Device Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Dry Powder Inhaler Device Sales Value by Region (2019-2024) & (%)

Table 44. Global Dry Powder Inhaler Device Sales Value by Region (2025-2030) & (%)

Table 45. Global Dry Powder Inhaler Device Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Dry Powder Inhaler Device Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Dry Powder Inhaler Device Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Dry Powder Inhaler Device Sales Volume by Region (2019-2024) & (%)

Table 49. Global Dry Powder Inhaler Device Sales Volume by Region (2025-2030) & (%)

Table 50. Global Dry Powder Inhaler Device Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Dry Powder Inhaler Device Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Dry Powder Inhaler Device Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Dry Powder Inhaler Device Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Dry Powder Inhaler Device Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Dry Powder Inhaler Device Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Dry Powder Inhaler Device Sales Volume, (2025-2030) & (K Units)

Table 57. GlaxoSmithKline Company Information

Table 58. GlaxoSmithKline Introduction and Business Overview

Table 59. GlaxoSmithKline Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. GlaxoSmithKline Dry Powder Inhaler Device Product Offerings

Table 61. GlaxoSmithKline Recent Development

Table 62. AstraZeneca Company Information

Table 63. AstraZeneca Introduction and Business Overview

Table 64. AstraZeneca Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. AstraZeneca Dry Powder Inhaler Device Product Offerings

Table 66. AstraZeneca Recent Development

Table 67. Boehringer Ingelheim Company Information

Table 68. Boehringer Ingelheim Introduction and Business Overview

Table 69. Boehringer Ingelheim Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Boehringer Ingelheim Dry Powder Inhaler Device Product Offerings

Table 71. Boehringer Ingelheim Recent Development

Table 72. Chiesi Company Information

Table 73. Chiesi Introduction and Business Overview

Table 74. Chiesi Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Chiesi Dry Powder Inhaler Device Product Offerings

Table 76. Chiesi Recent Development

Table 77. Cipla Company Information

Table 78. Cipla Introduction and Business Overview

Table 79. Cipla Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Cipla Dry Powder Inhaler Device Product Offerings

Table 81. Cipla Recent Development

Table 82. 3M Company Information

Table 83. 3M Introduction and Business Overview

Table 84. 3M Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. 3M Dry Powder Inhaler Device Product Offerings

Table 86. 3M Recent Development

Table 87. Hovione Company Information

Table 88. Hovione Introduction and Business Overview

Table 89. Hovione Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Hovione Dry Powder Inhaler Device Product Offerings

Table 91. Hovione Recent Development

Table 92. Mannkind Company Information

Table 93. Mannkind Introduction and Business Overview

Table 94. Mannkind Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Mannkind Dry Powder Inhaler Device Product Offerings

Table 96. Mannkind Recent Development

Table 97. Mylan Company Information

Table 98. Mylan Introduction and Business Overview

Table 99. Mylan Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. Mylan Dry Powder Inhaler Device Product Offerings

Table 101. Mylan Recent Development

Table 102. Novartis Company Information

Table 103. Novartis Introduction and Business Overview

Table 104. Novartis Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 105. Novartis Dry Powder Inhaler Device Product Offerings

Table 106. Novartis Recent Development

Table 107. Schering/Merck Company Information

Table 108. Schering/Merck Introduction and Business Overview

Table 109. Schering/Merck Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 110. Schering/Merck Dry Powder Inhaler Device Product Offerings

Table 111. Schering/Merck Recent Development

Table 112. Teva Company Information

Table 113. Teva Introduction and Business Overview

Table 114. Teva Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 115. Teva Dry Powder Inhaler Device Product Offerings

Table 116. Teva Recent Development

Table 117. Vectura Company Information

Table 118. Vectura Introduction and Business Overview

Table 119. Vectura Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 120. Vectura Dry Powder Inhaler Device Product Offerings

Table 121. Vectura Recent Development

Table 122. Key Raw Materials Lists

Table 123. Raw Materials Key Suppliers Lists

Table 124. Dry Powder Inhaler Device Downstream Customers

Table 125. Dry Powder Inhaler Device Distributors List

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Dry Powder Inhaler Device Product Picture

Figure 2. Global Dry Powder Inhaler Device Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Dry Powder Inhaler Device Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Dry Powder Inhaler Device Sales Volume (2019-2030) & (K Units)

Figure 5. Global Dry Powder Inhaler Device Sales Price (2019-2030) & (USD/Unit)

Figure 6. Dry Powder Inhaler Device Report Years Considered

Figure 7. Global Dry Powder Inhaler Device Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Dry Powder Inhaler Device Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Dry Powder Inhaler Device Revenue in 2023

Figure 10. Dry Powder Inhaler Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Single Dose Picture

Figure 12. Multi Dose Picture

Figure 13. Global Dry Powder Inhaler Device Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Dry Powder Inhaler Device Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Dry Powder Inhaler Device Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Dry Powder Inhaler Device Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Dry Powder Inhaler Device Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Asthma

Figure 19. Product Picture of COPD

Figure 20. Product Picture of Others

Figure 21. Global Dry Powder Inhaler Device Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Dry Powder Inhaler Device Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Dry Powder Inhaler Device Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Dry Powder Inhaler Device Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Dry Powder Inhaler Device Price by Application (2019-2030) & (USD/Unit)

Figure 26. North America Dry Powder Inhaler Device Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Dry Powder Inhaler Device Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Dry Powder Inhaler Device Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Dry Powder Inhaler Device Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Dry Powder Inhaler Device Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Dry Powder Inhaler Device Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Dry Powder Inhaler Device Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Dry Powder Inhaler Device Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Dry Powder Inhaler Device Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Dry Powder Inhaler Device Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Dry Powder Inhaler Device Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Dry Powder Inhaler Device Sales Volume (%), (2019-2030)

Figure 38. United States Dry Powder Inhaler Device Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Dry Powder Inhaler Device Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Dry Powder Inhaler Device Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Dry Powder Inhaler Device Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Dry Powder Inhaler Device Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Dry Powder Inhaler Device Sales Value by Application (%), 2023 VS 2030

Figure 44. China Dry Powder Inhaler Device Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Dry Powder Inhaler Device Sales Value by Type (%), 2023 VS 2030

Figure 46. China Dry Powder Inhaler Device Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Dry Powder Inhaler Device Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Dry Powder Inhaler Device Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Dry Powder Inhaler Device Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Dry Powder Inhaler Device Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Dry Powder Inhaler Device Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Dry Powder Inhaler Device Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Dry Powder Inhaler Device Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Dry Powder Inhaler Device Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Dry Powder Inhaler Device Sales Value by Application (%), 2023 VS 2030

Figure 56. India Dry Powder Inhaler Device Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Dry Powder Inhaler Device Sales Value by Type (%), 2023 VS 2030

Figure 58. India Dry Powder Inhaler Device Sales Value by Application (%), 2023 VS 2030

Figure 59. Dry Powder Inhaler Device Industrial Chain

Figure 60. Dry Powder Inhaler Device Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions